Anti-HPV Agent (Ointment)
Cervical Intraepithelial Neoplasia (CIN)
Phase 2Active (Phase 1/2 initiated in Korea in 2020)
Key Facts
Indication
Cervical Intraepithelial Neoplasia (CIN)
Phase
Phase 2
Status
Active (Phase 1/2 initiated in Korea in 2020)
Company
About KinoPharma
A clinical-stage biopharma developing novel small-molecule antiviral drugs, with a lead topical treatment for HPV-induced cervical lesions to prevent cervical cancer.
View full company profile